Hepatitis B reactivation despite entecavir prophylaxis in a patient with chronic lymphocytic leukaemia receiving bendamustine

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 2, 2012, Pages 510-511

  Rago, Angela ^a   Ridola, Lorenzo ^a   Lichtner, Miriam ^a   Mecarocci, Sergio ^a   Marocco, Raffaella ^a   Cenfra, Natalia ^a   Belvisi, Valeria ^a   Mastroianni, Claudio M ^a   Cimino, Giuseppe ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

CLL; HBV reactivation; Immunosuppressed patients

Indexed keywords

BENDAMUSTINE; ENTECAVIR; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; TENOFOVIR DISOPROXIL;

ADD ON THERAPY; ANTIVIRAL THERAPY; CANCER CHEMOTHERAPY; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; DRUG DOSE INCREASE; DRUG TOLERABILITY; DRUG WITHDRAWAL; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS REACTIVATION; HUMAN; INFECTION PREVENTION; LETTER; POLYMERASE CHAIN REACTION; SEROLOGY; SEROTYPING; SIDE EFFECT; VIRUS MUTATION; VIRUS REACTIVATION;

ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; CHEMOPREVENTION; DNA, VIRAL; GUANINE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; NITROGEN MUSTARD COMPOUNDS; VIRUS ACTIVATION;

EID: 84855833460     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr486     Document Type: Letter

References (5)

1. Lau GK. Hepatitis B reactivation after chemotherapy: two decades of clinical research. Hepatol Int 2008; 2: 152-62.
2. Uchiyama M, Tamai Y, Ikeda T. Entecavir as prophylaxis against hepatitis B virus reactivation following chemotherapy for lymphoma. Int J Infect Dis 2010; 14: 265-6.
3. Colson P, Borentain P, Coso D et al. Entecavir as a first-line treatment for HBV reactivation following polychemotherapy for lymphoma. Br J Haematol 2008; 143: 148-50.
4. Sanchez MJ, Buti M, Homs M et al. Successful use of entecavir for a severe case of reactivation of hepatitis B virus following polychemotherapy containing rituximab. J Hepatol 2009; 51: 1091-6.
5. Rago A, Lichtner M, Mecarocci S et al. Antiviral treatment including entecavir plus tenofovir disoproxil fumarate for HBV reactivation following a rituximab-based regimen. Antivir Ther 2010; 15: 929-32.